Skip to main content

Advertisement

Log in

Power of national economy, disease control and employment status in patients with RA—an analytical multi-site ecological study

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

In rheumatology, sufficient disease control is a central part of the treatment concept. However, modern treatment strategies are associated with a substantial economic burden for health care systems. Ecological studies offer the unique opportunity to analyse differences between groups as well as group level effects. In the present analytical multi-site ecological study, we investigated whether more powerful national economies as measured by the gross domestic product per capita (GDPpc) are associated with better disease control in RA patients as measured by the disease activity score 28 (DAS28). We used aggregated data on RA patients from the recently published COMORA study as well as the World Health Organization database. There was a strong negative correlation between DAS28 and GDPpc (r = −0.815; p = 0.0002). Adjustment for sex, smoking status, disease duration or current employment status did not significantly change this association. There was a strong, negative correlation between DAS28 and age (r = −0.870; p < 0.001) and a strong, positive correlation between GDPpc and age (r = 0.737; p = 0.002). Adjustment for age reduced the regression coefficient (DAS28/GDPpc) to −0.000018 (p = 0.054). There was a negative correlation between DAS28 and current employment status (r = −0.642; p = 0.008) and a positive correlation between GDPpc and employment status (r = 0.722; p = 0.002). In conclusion, there is evidence of an association between disease control and GDPpc. This association is alleviated after adjustment for age. Of note, in countries with higher GDPpc, a higher proportion of RA patients are currently employed. This is true despite the fact that RA patients in countries with higher GDPpc are also older.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Symmons DPM (2005) Looking back: rheumatoid arthritis—aetiology, occurrence and mortality. Rheumatology (Oxford) 44(Suppl 4):iv14–iv17

    Google Scholar 

  2. Machold KP, Stamm TA, Nell VPK et al (2007) Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiograph progression over the first years of disease. Rheumatology (Oxford) 46:342–9

    Article  CAS  Google Scholar 

  3. Fuchs HA, Kaye JJ, Callahan LF, Nance EP (1989) Pincus T evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 16(5):585–91

    CAS  PubMed  Google Scholar 

  4. Aletaha D, Smolen J (2005) The simplified disease activity index (SDAI) and the clinical disease activity index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 23:S100

    CAS  PubMed  Google Scholar 

  5. Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D, T2T Expert Committee (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69:631–637

    Article  PubMed Central  PubMed  Google Scholar 

  6. Smolen JS (2012) Treat-to-target: rationale and strategies. Clin Exp Rheumatol 30:S2–S6

    PubMed  Google Scholar 

  7. Kievit W, Fransen J, de Waal Malefijt MC, den Broeder AA, van Riel PL (2013) Treatment changes and improved outcomes in RA: an overview of a large inception cohort from 1989 to 2009. Rheumatology (Oxford) 52:1500–8

    Article  Google Scholar 

  8. Aga AB, Lie E, Uhlig T, Olsen IC, Wierød A, Kalstad S, Rødevand E, Mikkelsen K, Kvien TK, Haavardsholm EA (2015) Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000–2010. Ann Rheum Dis 74:381–8

    Article  CAS  PubMed  Google Scholar 

  9. Ziegler S, Huscher D, Karberg K, Krause A, Wassenberg S, Zink A (2010) Trends in treatment and outcomes of rheumatoid arthritis in Germany 1997–2007: results from the national database of the German collaborative arthritis centres. Ann Rheum Dis 69:1803–8

    Article  PubMed  Google Scholar 

  10. Huscher D, Merkesdal S, Thiele K, Zeidler H, Schneider M, Zink A (2006) Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis 65:1175–1183

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Huscher D, Mittendorf T, von Hinüber U, Kötter I, Hoese G, Pfäfflin A, Bischoff S, Zink A; for the German Collaborative Arthritis Centres (2014) Evolution of cost structures in rheumatoid arthritis over the past decade. Ann Rheum Dis. Jan 9

  12. Hennekens CH, Buring JA (1987) Epidemiology in medicine. Lippincott Williams & Wilkins

  13. Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH et al (2014) Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis 73(1):62–8

    Article  PubMed Central  PubMed  Google Scholar 

  14. Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–24

    Article  CAS  PubMed  Google Scholar 

  15. Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–8

    Article  CAS  PubMed  Google Scholar 

  16. Mathers CD, Sadana R, Salomon JA, Murray CJ, Lopez AD (2001) Healthy life expectancy in 191 countries, 1999. World Health Report 2000. Lancet 357:1685–81

    Article  CAS  PubMed  Google Scholar 

  17. Pieringer H, Pichler M (2011) Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications. QJM 104:13–26

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Herwig Pieringer.

Additional information

Herwig Pieringer holds MD and MBA degrees, General Hospital Linz.

Rudolf Puchner is a rheumatologist in private practice and holds MD, MSc, and MBA degrees.

Erich Pohanka holds a MD degree, General Hospital Linz.

Kathrin Danninger holds a MD degree, Klinikum Wels-Grieskirchen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pieringer, H., Puchner, R., Pohanka, E. et al. Power of national economy, disease control and employment status in patients with RA—an analytical multi-site ecological study. Clin Rheumatol 35, 461–465 (2016). https://doi.org/10.1007/s10067-015-2918-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-015-2918-x

Keywords

Navigation